Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea

BACKGROUND: For the first time in Korea, we aimed to study the efficacy and safety of cannabidiol (CBD), which is emerging as a new alternative in treating epileptic encephalopathies. METHODS: This study was conducted retrospectively with patients between the ages of 2–18 years diagnosed with Lennox...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Korean Med Sci
Autors principals: Koo, Chung Mo, Kim, Se Hee, Lee, Joon Soo, Park, Byung-Joo, Lee, Hae Kook, Kim, Heung Dong, Kang, Hoon-Chul
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7769699/
https://ncbi.nlm.nih.gov/pubmed/33372424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e427
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars